Myriad's Q4 Revenues Rise 9 Percent; 2010 Revenues up 11 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Myriad Genetics said Tuesday after the close of market that revenues for its fiscal fourth quarter rose 9 percent, with its women's health revenues bouncing 16 percent year over year.

The company also said that revenues rose 11 percent for full-year 2010 from full-year 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.